Filing Details
- Accession Number:
- 0001298709-24-000014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-13 17:44:06
- Reporting Period:
- 2024-09-12
- Accepted Time:
- 2024-09-13 17:44:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1711279 | Krystal Biotech Inc. | KRYS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1298709 | S Krish Krishnan | C/O Krystal Biotech, Inc. 2100 Wharton Street, Suite 701 Pittsburgh PA 15203 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-09-12 | 3,957 | $195.16 | 1,583,305 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-09-12 | 6,458 | $195.72 | 1,576,847 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-09-12 | 1,696 | $197.04 | 1,575,151 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-09-12 | 2,086 | $198.08 | 1,573,065 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-09-12 | 4,008 | $198.93 | 1,569,057 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-09-12 | 3,600 | $200.15 | 1,565,457 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-09-12 | 2,395 | $200.98 | 1,563,062 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-09-12 | 800 | $201.81 | 1,562,262 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-09-12 | 8,497 | $195.43 | 1,517,385 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-09-12 | 2,727 | $196.07 | 1,514,658 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-09-12 | 1,385 | $197.55 | 1,513,273 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-09-12 | 3,392 | $198.43 | 1,509,881 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-09-12 | 2,945 | $199.22 | 1,506,936 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-09-12 | 4,159 | $200.41 | 1,502,777 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-09-12 | 1,895 | $201.52 | 1,500,882 | No | 4 | S | Indirect | By Spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 90,000 | Indirect | By Krishnan Spousal Trust |
Common Stock | 50,000 | Indirect | By Krishnan Family Trust |
Footnotes
- The sales reported were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024. The Rule 10b5-1 trading plan started on September 12, 2024 and will terminate on September 13, 2025 and contemplates quarterly sales of 25,000 shares of common stock with a limit price of $150.00 per share.
- The transaction was executed in multiple trades ranging from $194.4500 to $195.4300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $195.4500 to $196.2600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $196.4900 to $197.4600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $197.5500 to $198.5200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $198.5500 to $199.4300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $199.5900 to $200.5700. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $200.6200 to $201.5900. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $201.6900 to $201.9500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The sales reported were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Suma M. Krishnan, on June 13, 2024. The Rule 10b5-1 trading plan started on September 12, 2024 and will terminate on September 13, 2025 and contemplates quarterly sales of 25,000 shares of common stock with a limit price of $150.00 per share.
- These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma M. Krishnan.
- The transaction was executed in multiple trades ranging from $194.7000 to $195.6800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person.
- The transaction was executed in multiple trades ranging from $195.8300 to $196.7600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $196.8650 to $197.8500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $197.8700 to $198.8600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $198.8700 to $199.8600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $199.8800 to $200.8700. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $200.9800 to $201.9400. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Directly beneficially owned by the Krishnan Family Trust. The Reporting Person and his spouse are each joint beneficial owners of the trust with joint voting and investment control.